An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
A Phase 2, Two-arm Multicenter, Open-Label Study to Determine the Efficacy and the Safety of Two Different Dose Regimens of a Pan-FGFR Tyrosine Kinase Inhibitor JNJ-42756493 in Subjects With Metastatic or Surgically Unresectable Urothelial Cancer With FGFR Genomic Alterations
Sponsor: Janssen Research & Development, LLC
A PHASE2 clinical study on Urothelial Cancer, this trial is ongoing. The trial is conducted by Janssen Research & Development, LLC and has accumulated 74 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
74 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting PHASE2
-
Jan 2026 — Feb 2026 [monthly]
Active Not Recruiting PHASE2
-
Dec 2025 — Jan 2026 [monthly]
Active Not Recruiting PHASE2
-
Nov 2025 — Dec 2025 [monthly]
Active Not Recruiting PHASE2
-
Oct 2025 — Nov 2025 [monthly]
Active Not Recruiting PHASE2
▶ Show 69 earlier versions
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE2
-
Jul 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE2
-
Jun 2025 — Jul 2025 [monthly]
Active Not Recruiting PHASE2
-
May 2025 — Jun 2025 [monthly]
Active Not Recruiting PHASE2
-
Mar 2025 — May 2025 [monthly]
Active Not Recruiting PHASE2
-
Feb 2025 — Mar 2025 [monthly]
Active Not Recruiting PHASE2
-
Jan 2025 — Feb 2025 [monthly]
Active Not Recruiting PHASE2
-
Nov 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE2
-
Oct 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE2
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
-
Nov 2023 — Jun 2024 [monthly]
Active Not Recruiting PHASE2
-
Sep 2023 — Nov 2023 [monthly]
Active Not Recruiting PHASE2
-
Aug 2023 — Sep 2023 [monthly]
Active Not Recruiting PHASE2
-
Jun 2023 — Aug 2023 [monthly]
Active Not Recruiting PHASE2
-
May 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE2
-
Apr 2023 — May 2023 [monthly]
Active Not Recruiting PHASE2
-
Mar 2023 — Apr 2023 [monthly]
Active Not Recruiting PHASE2
-
Feb 2023 — Mar 2023 [monthly]
Active Not Recruiting PHASE2
-
Jan 2023 — Feb 2023 [monthly]
Active Not Recruiting PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Nov 2022 — Dec 2022 [monthly]
Recruiting PHASE2
Status: Active Not Recruiting → Recruiting
-
Sep 2022 — Nov 2022 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Recruiting PHASE2
-
Jun 2022 — Jul 2022 [monthly]
Recruiting PHASE2
-
May 2022 — Jun 2022 [monthly]
Recruiting PHASE2
-
Apr 2022 — May 2022 [monthly]
Recruiting PHASE2
-
Mar 2022 — Apr 2022 [monthly]
Recruiting PHASE2
-
Feb 2022 — Mar 2022 [monthly]
Recruiting PHASE2
-
Jan 2022 — Feb 2022 [monthly]
Recruiting PHASE2
-
Dec 2021 — Jan 2022 [monthly]
Recruiting PHASE2
-
Nov 2021 — Dec 2021 [monthly]
Recruiting PHASE2
-
Oct 2021 — Nov 2021 [monthly]
Recruiting PHASE2
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE2
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
May 2021 — Jun 2021 [monthly]
Recruiting PHASE2
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE2
-
Mar 2021 — Apr 2021 [monthly]
Recruiting PHASE2
-
Feb 2021 — Mar 2021 [monthly]
Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE2
Status: Active Not Recruiting → Recruiting
-
Aug 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE2
-
Jul 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE2
-
Apr 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE2
-
Feb 2020 — Apr 2020 [monthly]
Active Not Recruiting PHASE2
-
Jan 2020 — Feb 2020 [monthly]
Active Not Recruiting PHASE2
-
Nov 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE2
-
Sep 2019 — Oct 2019 [monthly]
Active Not Recruiting PHASE2
-
Jul 2019 — Sep 2019 [monthly]
Active Not Recruiting PHASE2
-
Apr 2019 — Jul 2019 [monthly]
Active Not Recruiting PHASE2
-
Mar 2019 — Apr 2019 [monthly]
Active Not Recruiting PHASE2
Status: Enrolling By Invitation → Active Not Recruiting
-
Dec 2018 — Mar 2019 [monthly]
Enrolling By Invitation PHASE2
Status: Recruiting → Enrolling By Invitation
-
Sep 2018 — Dec 2018 [monthly]
Recruiting PHASE2
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Jan 2018 — Jun 2018 [monthly]
Recruiting PHASE2
-
Dec 2017 — Jan 2018 [monthly]
Recruiting PHASE2
-
Oct 2017 — Dec 2017 [monthly]
Recruiting PHASE2
-
Sep 2017 — Oct 2017 [monthly]
Recruiting PHASE2
-
Jul 2017 — Sep 2017 [monthly]
Recruiting PHASE2
-
May 2017 — Jul 2017 [monthly]
Recruiting PHASE2
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Janssen Research & Development, LLC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalst, Belgium , Angers, France , Aurora, United States , Badalona, Spain , Bangalore, India , Barcelona, Spain , Barnaul, Russia , Beer Yaakov, Israel , Beersheba, Israel , Berlin, Germany and 95 more locations